113 related articles for article (PubMed ID: 7563711)
1. [Quantitative assay of anti-HCV core antibody with JCC-2 ELISA: anti-HCV core IgG antibody].
Nakashima T; Mizuno K
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):247-52. PubMed ID: 7563711
[No Abstract] [Full Text] [Related]
2. [Immunodominant regions of core protein of hepatitis C virus and antibody-assays employing two recombinant core proteins, p22 and JCC4].
Ohba H; Chiba J; Miyamura T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):212-23. PubMed ID: 7563702
[No Abstract] [Full Text] [Related]
3. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
6. [HCV associated antibodies (anti-HCV, anti-HCV core, anti-C14, anti-NS)].
Ishikawa K; Koyama T; Isobe N
Nihon Rinsho; 2010 Jun; 68 Suppl 6():446-9. PubMed ID: 20942100
[No Abstract] [Full Text] [Related]
7. [An assay system for ARIMA14 antibody].
Sho Y; Oketani M; Miyazaki H; Arima T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):236-40. PubMed ID: 7563708
[No Abstract] [Full Text] [Related]
8. [Antibodies generated against hepatitis C virus (HCV) core antigen: IgM and IgA antibody against HCV core].
Sato S; Fujiyama S; Chikazawa H; Tanaka M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):253-9. PubMed ID: 7563714
[No Abstract] [Full Text] [Related]
9. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.
Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T
J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894
[TBL] [Abstract][Full Text] [Related]
10. [Serodiagnosis of HCV infection by means of HCV core antibodies (CP-9 Ab, CP-10 Ab)].
Nagai K; Saruki K; Kako M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):224-9. PubMed ID: 7563705
[No Abstract] [Full Text] [Related]
11. [Clinicopathological studies on the solitary positive cases of HCV core antibody].
Yamashita K; Imai K; Kodama T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):562-4. PubMed ID: 7563826
[No Abstract] [Full Text] [Related]
12. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
13. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological studies of anti-HCV P1P4 core antibody].
Shibuya A; Asano A; Tsuchihashi T; Sakurai K; Takeuchi A; Shibata H
Rinsho Byori; 1995 Mar; 43(3):285-9. PubMed ID: 7538180
[TBL] [Abstract][Full Text] [Related]
15. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
Nagayama R; Shoji S; Miyake K
Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
[TBL] [Abstract][Full Text] [Related]
16. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
17. Double-antigen sandwich ELISA for the detection of anti-hepatitis C virus antibodies.
He J; Xiu B; Wang G; Chen K; Feng X; Song X; Zhu C; Ling S; Zhang H
J Virol Methods; 2011 Jan; 171(1):163-8. PubMed ID: 21029749
[TBL] [Abstract][Full Text] [Related]
18. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
Quiroga JA; Castillo I; Llorente S; Bartolomé J; Barril G; Carreño V
J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
[TBL] [Abstract][Full Text] [Related]
19. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
20. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
